Evidence map›Paper›PMID 34515581›Full record

ArticleAmerican journal of men's health

Comparison of 3- and 6-Month Outcomes of Combined Oral L-Carnitine Fumarate and Acetyl-L-Carnitine Therapy, Included in an Antioxidant Formulation, in Patients with Idiopathic Infertility.

Marek Szymański, Tomasz Wandtke, Karolina Wasilow, Marek Andryszczyk, Radosław Janicki, Piotr Domaracki

Open access · goldAbstract read
In one paragraph

Article in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marek SzymańskiDepartment of Women's Health, Sexology and Reproductive Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Bydgoszcz, Poland.
Tomasz WandtkeNZOZ Medical Center, Clinic of Infertility Treatment "Genesis", Bydgoszcz, Poland.
Karolina WasilowNZOZ Medical Center, Clinic of Infertility Treatment "Genesis", Bydgoszcz, Poland.
Marek AndryszczykNZOZ Medical Center, Clinic of Infertility Treatment "Genesis", Bydgoszcz, Poland.ORCID 0000-0003-2732-8631
Radosław JanickiNZOZ Medical Center, Clinic of Infertility Treatment "Genesis", Bydgoszcz, Poland.
Piotr DomarackiGynecology and Oncological Gynecology Ward, 10th Military Research Hospital and Polyclinic, IPHC, Bydgoszcz, Poland.ORCID 0000-0002-2745-530X
1 Military Clinical Hospital with Outpatient Clinic · PLNicolaus Copernicus University · PLBydgoszcz University of Science and Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The male factor is responsible for infertility in about 35-40% of all cases. Idiopathic oligo- and/or astheno- and/or therato-zoospermia is one of the most common male fertility disorders and remains a significant therapeutic challenge. The primary cause of idiopathic male infertility remains unknown but seems to be associated with oxidative stress. Objective: The use of antioxidative formulation to improve qualitative and quantitative deficiencies in the male gametes.In total, 78 subjects were treated with a combination of 1,725 mg L-carnitine fumarate, 500 mg acetyl-L-carnitine, 90 mg vitamin C, 20 mg coenzyme Q

Indexed as

AcetylcarnitineInfertility, MaleAntioxidantsCarnitineFumaratesHumansMaleSperm MotilityAcetylcarnitineAntioxidantsCarnitineFumaratesmale infertilityoxidative stresssemenspermsperm motility

Identifiers

PMID34515581
PMCPMC8442503
OpenAlexW3200902063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.